🇺🇸 FDA
Pipeline program

HEC116094

HEC116094-P-01/CRC-C2104

Phase 1 small_molecule completed

Quick answer

HEC116094 for Influenza is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Influenza
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials